47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 3,8 | -0 | -100 |
EBITDA | 3,4 | 6,1 | 2,9 | -52,5 |
Short time liabilities | 37 | 41,5 | 49,2 | 18,4 |
Equity capital | -6,1 | -3,1 | -3,4 | -8,8 |
Operating profit (EBIT) | 1,8 | 4,8 | 1,6 | -67,1 |
Assets | 46,2 | 52,7 | 58,9 | 11,7 |
Net profit (loss) | 0,8 | 3 | -0,3 | -109,2 |
Cash | 1,7 | 3,9 | 3,5 | -10,4 |
Net income from sale | 203,8 | 238,7 | 268,2 | 12,3 |
Liabilities and provisions for liabilities | 52,3 | 55,8 | 62,2 | 11,6 |
Working assets | 32,3 | 40,2 | 47,5 | 18,2 |
Depreciation | 1,5 | 1,4 | 1,3 | -1,4 |
% | % | % | p.p. | |
Profitability of capital | -14 | -95,8 | 8,1 | 103,9 |
Equity capital to total assets | -13,1 | -5,9 | -5,7 | 0,2 |
Gross profit margin | 0,5 | 1,6 | -0 | -1,6 |
EBITDA Margin | 1,7 | 2,6 | 1,1 | -1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 66 | 64 | 67 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane